1. Home
  2. VTAK vs SPRC Comparison

VTAK vs SPRC Comparison

Compare VTAK & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • SPRC
  • Stock Information
  • Founded
  • VTAK 2002
  • SPRC 2004
  • Country
  • VTAK United States
  • SPRC Israel
  • Employees
  • VTAK N/A
  • SPRC N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTAK Health Care
  • SPRC Health Care
  • Exchange
  • VTAK Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • VTAK 3.1M
  • SPRC 3.4M
  • IPO Year
  • VTAK 2018
  • SPRC N/A
  • Fundamental
  • Price
  • VTAK $0.24
  • SPRC $6.65
  • Analyst Decision
  • VTAK
  • SPRC
  • Analyst Count
  • VTAK 0
  • SPRC 0
  • Target Price
  • VTAK N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • VTAK 41.3M
  • SPRC 17.7K
  • Earning Date
  • VTAK 08-13-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • VTAK N/A
  • SPRC N/A
  • EPS Growth
  • VTAK N/A
  • SPRC N/A
  • EPS
  • VTAK N/A
  • SPRC N/A
  • Revenue
  • VTAK $481,000.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • VTAK $822.86
  • SPRC N/A
  • Revenue Next Year
  • VTAK $168.42
  • SPRC N/A
  • P/E Ratio
  • VTAK N/A
  • SPRC N/A
  • Revenue Growth
  • VTAK 9.57
  • SPRC N/A
  • 52 Week Low
  • VTAK $0.16
  • SPRC $4.14
  • 52 Week High
  • VTAK $4.76
  • SPRC $37.59
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 45.34
  • SPRC 57.06
  • Support Level
  • VTAK $0.22
  • SPRC $6.25
  • Resistance Level
  • VTAK $0.25
  • SPRC $7.27
  • Average True Range (ATR)
  • VTAK 0.02
  • SPRC 0.54
  • MACD
  • VTAK -0.01
  • SPRC 0.02
  • Stochastic Oscillator
  • VTAK 11.79
  • SPRC 68.94

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: